Mitochondrial, cell cycle control and neuritogenesis alterations in an iPSC-based neurodevelopmental model for schizophrenia
- PMID: 37039888
- DOI: 10.1007/s00406-023-01605-x
Mitochondrial, cell cycle control and neuritogenesis alterations in an iPSC-based neurodevelopmental model for schizophrenia
Abstract
Schizophrenia is a severe psychiatric disorder of neurodevelopmental origin that affects around 1% of the world's population. Proteomic studies and other approaches have provided evidence of compromised cellular processes in the disorder, including mitochondrial function. Most of the studies so far have been conducted on postmortem brain tissue from patients, and therefore, do not allow the evaluation of the neurodevelopmental aspect of the disorder. To circumvent that, we studied the mitochondrial and nuclear proteomes of neural stem cells (NSCs) and neurons derived from induced pluripotent stem cells (iPSCs) from schizophrenia patients versus healthy controls to assess possible alterations related to energy metabolism and mitochondrial function during neurodevelopment in the disorder. Our results revealed differentially expressed proteins in pathways related to mitochondrial function, cell cycle control, DNA repair and neuritogenesis and their possible implication in key process of neurodevelopment, such as neuronal differentiation and axonal guidance signaling. Moreover, functional analysis of NSCs revealed alterations in mitochondrial oxygen consumption in schizophrenia-derived cells and a tendency of higher levels of intracellular reactive oxygen species (ROS). Hence, this study shows evidence that alterations in important cellular processes are present during neurodevelopment and could be involved with the establishment of schizophrenia, as well as the phenotypic traits observed in adult patients. Neural stem cells (NSCs) and neurons were derived from induced pluripotent stem cells (iPSCs) from schizophrenia patients and controls. Proteomic analyses were performed on the enriched mitochondrial and nuclear fractions of NSCs and neurons. Whole-cell proteomic analysis was also performed in neurons. Our results revealed alteration in proteins related to mitochondrial function, cell cycle control, among others. We also performed energy pathway analysis and reactive oxygen species (ROS) analysis of NSCs, which revealed alterations in mitochondrial oxygen consumption and a tendency of higher levels of intracellular ROS in schizophrenia-derived cells.
Keywords: Mitochondrion; Neural cells; Neurodevelopment; Nucleus; Proteomics; Schizophrenia; iPSCs.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
Similar articles
-
Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients.Mol Psychiatry. 2013 Oct;18(10):1067-76. doi: 10.1038/mp.2013.67. Epub 2013 Jun 4. Mol Psychiatry. 2013. PMID: 23732879
-
Comparing the mitochondrial signatures in ESCs and iPSCs and their neural derivations.Cell Cycle. 2022 Oct;21(20):2206-2221. doi: 10.1080/15384101.2022.2092185. Epub 2022 Jul 10. Cell Cycle. 2022. PMID: 35815665 Free PMC article.
-
Revisiting Mitochondrial Function and Metabolism in Pluripotent Stem Cells: Where Do We Stand in Neurological Diseases?Mol Neurobiol. 2017 Apr;54(3):1858-1873. doi: 10.1007/s12035-016-9714-8. Epub 2016 Feb 18. Mol Neurobiol. 2017. PMID: 26892627 Review.
-
Dopamine signaling impairs ROS modulation by mitochondrial hexokinase in human neural progenitor cells.Biosci Rep. 2021 Dec 22;41(12):BSR20211191. doi: 10.1042/BSR20211191. Biosci Rep. 2021. PMID: 34821365 Free PMC article.
-
Pluripotent stem cells as a model to study oxygen metabolism in neurogenesis and neurodevelopmental disorders.Arch Biochem Biophys. 2013 Jun;534(1-2):3-10. doi: 10.1016/j.abb.2012.10.009. Epub 2012 Oct 27. Arch Biochem Biophys. 2013. PMID: 23111185 Review.
Cited by
-
The Roles of hnRNP Family in the Brain and Brain-Related Disorders.Mol Neurobiol. 2024 Jun;61(6):3578-3595. doi: 10.1007/s12035-023-03747-4. Epub 2023 Nov 24. Mol Neurobiol. 2024. PMID: 37999871 Review.
-
Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models.J Psychiatry Neurosci. 2024 Mar 15;49(2):E109-E125. doi: 10.1503/jpn.230112. Print 2024 Jan-Feb. J Psychiatry Neurosci. 2024. PMID: 38490647 Free PMC article. Review.
-
Imaging Transcriptomics of the Brain for Schizophrenia.Alpha Psychiatry. 2024 Jan 1;25(1):9-14. doi: 10.5152/alphapsychiatry.2024.231369. eCollection 2024 Jan. Alpha Psychiatry. 2024. PMID: 38799487 Free PMC article. Review.
-
Patient iPSC-derived neural progenitor cells display aberrant cell cycle control, p53, and DNA damage response protein expression in schizophrenia.BMC Psychiatry. 2024 Oct 31;24(1):757. doi: 10.1186/s12888-024-06127-x. BMC Psychiatry. 2024. PMID: 39482642 Free PMC article.
-
The 2024 Report on the Human Proteome from the HUPO Human Proteome Project.J Proteome Res. 2024 Dec 6;23(12):5296-5311. doi: 10.1021/acs.jproteome.4c00776. Epub 2024 Nov 8. J Proteome Res. 2024. PMID: 39514846 Free PMC article. Review.
References
-
- Kahn RS, Sommer IE, Murray RM et al (2015) Schizophrenia. Nat Rev Dis Prim. https://doi.org/10.1038/nrdp.2015.67 - DOI - PubMed
-
- Insel TR (2010) Rethinking schizophrenia. Nature 468:187–193. https://doi.org/10.1038/nature09552 - DOI - PubMed
-
- Martins-de-Souza D, Harris LW, Guest PC, Bahn S (2011) The role of energy metabolism dysfunction and oxidative stress in schizophrenia revealed by proteomics. Antioxid Redox Signal 15:2067–2079. https://doi.org/10.1089/ars.2010.3459 - DOI - PubMed
-
- Nascimento JM, Martins-de-Souza D (2015) The proteome of schizophrenia. npj Schizophr 1:14003. https://doi.org/10.1038/npjschz.2014.3 - DOI - PubMed - PMC
-
- Zuccoli GS, Saia-Cereda VM, Nascimento JM, Martins-de-Souza D (2017) The energy metabolism dysfunction in psychiatric disorders postmortem brains: Focus on proteomic evidence. Front Neurosci 11:1–14. https://doi.org/10.3389/fnins.2017.00493 - DOI
MeSH terms
Substances
Grants and funding
- 2016/04912-2/Fundação de Amparo à Pesquisa do Estado de São Paulo
- 2018/14666-4/Fundação de Amparo à Pesquisa do Estado de São Paulo
- 2014/21035-0/Fundação de Amparo à Pesquisa do Estado de São Paulo
- 2015/15626-8/Fundação de Amparo à Pesquisa do Estado de São Paulo
- 2017/25588-1/Fundação de Amparo à Pesquisa do Estado de São Paulo
LinkOut - more resources
Full Text Sources
Medical